Keck School Faculty

William Tseng, MD
William Tseng, MD
Associate Professor of Clinical Surgery
Surgery
HCC 1510 San Pablo Health Sciences Campus Los Angeles
William W Tseng, MD is Associate Professor of Surgery at the Keck School of Medicine at USC. He obtained his undergraduate and medical degrees from Northwestern University, under the Honors Program in Medical Education. He did residency training in General Surgery at the University of California at San Francisco and then completed subspecialty fellowship training in Surgical Oncology at the University of Texas M.D. Anderson Cancer Center.

Dr. Tseng‘s clinical focus and expertise is in soft tissue sarcoma and melanoma. He has published extensively and won several awards for work done in both of these disease areas. Dr. Tseng’s research interest is in tumor immunology and immunotherapy. He completed dedicated research fellowships in immunology at Stanford University and M.D. Anderson.

Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2 Ann Surg Oncol. 2019 Sep 09. . View in PubMed

Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma BMJ Case Rep. 2019 May 13; 12(5). . View in PubMed

Staging systems and nomograms in soft tissue sarcoma: outcome prediction by categorization or personalization? Chin Clin Oncol. 2019 Mar 06.. View in PubMed

Surgical management of retroperitoneal sarcoma and opportunities for global collaboration Chin Clin Oncol. 2018 Aug; 7(4):39. . View in PubMed

Multidisciplinary management of soft tissue sarcoma Chin Clin Oncol. 2018 Aug; 7(4):34. . View in PubMed

Second Primary Malignancies in Patients with Well-differentiated/Dedifferentiated Liposarcoma Anticancer Res. 2018 Jun; 38(6):3535-3542. . View in PubMed

Imaging of liposarcomas for clinicians: Characteristic features and differential considerations J Surg Oncol. 2018 May; 117(6):1195-1203. . View in PubMed

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma Eur J Surg Oncol. 2018 06; 44(6):810-815. . View in PubMed

Retroperitoneal sarcomas: Big tumors that involve more than just "Getting it Out" J Surg Oncol. 2018 Jan; 117(1):5-6. . View in PubMed

Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma J Surg Oncol. 2018 Jan; 117(1):7-11. . View in PubMed

Surgery for recurrence in retroperitoneal leiomyosarcoma: Is it all about selection? J Surg Oncol. 2017 Sep; 116(3):267-268.. View in PubMed

Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations Ther Adv Med Oncol. 2017 Aug; 9(8):533-550. . View in PubMed

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard Sci Rep. 2017 09 19; 7(1):11836. . View in PubMed

An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer Cancer Res. 2017 08 01; 77(15):4158-4170. . View in PubMed

The role of margins in extremity soft tissue sarcoma J Surg Oncol. 2016 Mar; 113(3):333-8. . View in PubMed

The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): "Red wine or white"? Ann Surg Oncol. 2016 12; 23(13):4418-4420.. View in PubMed

Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma Front Oncol. 2016; 6:134. . View in PubMed

Recent advances in the management of liposarcoma F1000Res. 2016; 5:2907. . View in PubMed

Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma Cancer. 2015 Oct 15; 121(20):3659-67. . View in PubMed

Contemporary Management of Retroperitoneal Soft Tissue Sarcomas Curr Oncol Rep. 2015 Aug; 17(8):39. . View in PubMed

Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management BMJ Case Rep. 2015 Jul 08; 2015. . View in PubMed

Contemporary imaging of soft tissue sarcomas J Surg Oncol. 2015 Apr; 111(5):496-503. . View in PubMed

Follow-up of the soft tissue sarcoma patient J Surg Oncol. 2015 Apr; 111(5):641-5. . View in PubMed

Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes Ann Surg Oncol. 2015 Apr; 22(4):1068-72. . View in PubMed

Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma Sarcoma. 2015; 2015:547460. . View in PubMed

Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014 Jul; 21(7):2136-43.. View in PubMed

Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications CA Cancer J Clin. 2014 May-Jun; 64(3):195-206. . View in PubMed

Stimulants and the lung : review of literature Clin Rev Allergy Immunol. 2014 Feb; 46(1):82-100. . View in PubMed

Potential for immunotherapy in soft tissue sarcoma Hum Vaccin Immunother. 2014; 10(11):3117-24. . View in PubMed

Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases BMC Anesthesiol. 2013 Jul 17; 13(1):15. . View in PubMed

Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results Cancers (Basel). 2013 May 10; 5(2):529-49. . View in PubMed

Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications Am J Surg Pathol. 2012 Jun; 36(6):941-4. . View in PubMed

Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures World J Surg Oncol. 2011 Nov 04; 9:143. . View in PubMed

Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape? Cancers (Basel). 2011 Feb 21; 3(1):730-46.. View in PubMed

Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host Clin Cancer Res. 2010 Jul 15; 16(14):3684-95. . View in PubMed

Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation J Immunol. 2009 Dec 01; 183(11):7196-203. . View in PubMed

In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines Mol Pharm. 2009 Jul-Aug; 6(4):1160-9. . View in PubMed

Giant cutaneous melanomas: evidence for primary tumour induced dormancy in metastatic sites? BMJ Case Rep. 2009; 2009.. View in PubMed

T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size Bioconjug Chem. 2009 Jan; 20(1):111-9. . View in PubMed

Orthotopic mouse model of colorectal cancer J Vis Exp. 2007; (10):484. . View in PubMed

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors Br J Cancer. 2001 Aug 17; 85(4):584-9. . View in PubMed

Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms Cancer Res. 2001 Feb 15; 61(4):1464-8. . View in PubMed

Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis Int J Oncol. 2001 Feb; 18(2):221-6. . View in PubMed

Powered by SC CTSI
Go to Top